IMPROVEMENTS IN RECOMBINANT HUMAN SERUM ALBUMIN FOR BIOPHARMACEUTICAL PURPOSES

Recombinant human serum albumin (OsrHSA) has emerged as a major innovation in the sector of biopharmaceuticals, providing promising enhancements across various clinical and industrial purposes. With its structural similarity to Normally derived human serum albumin, OsrHSA delivers a safer, much more reliable option for therapeutic use, particularly